Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium(TM) as Company Prepares for SOTERIA Trial Launch
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium(TM) as Company Prepares for SOTERIA Trial Launch Oral presentation provides additional scientific rationale on Krabbe disease, one of four LSDs in the Phase 2 SOTERIA basket trial designed to evaluate the safety and clinical activity of lead drug candidate PLX-200 GlobeNewswire February […]